Literature DB >> 5100497

Drug-induced pulmonary hypertension?

F Follath, F Burkart, W Schweizer.   

Abstract

Of 40 patients with obstructive pulmonary hypertension studied in Basle, Switzerland, during the period 1966-68, 32 had been taking an anorectic drug, aminorex fumarate. Rapidly progressing exertional dyspnoea, central chest pain, and syncope on effort were characteristic features. The absence of the usual causes of pulmonary vascular disease seems to suggest the possibility of drug-induced pulmonary hypertension. Further studies are necessary, however, to clarify the role of aminorex fumarate in this condition.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5100497      PMCID: PMC1794933          DOI: 10.1136/bmj.1.5743.265

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  16 in total

1.  POSTMORTEM ARTERIOGRAPHIC STUDIES OF THE HUMAN LUNG IN PULMONARY EMBOLIZATION.

Authors:  G T SMITH; G J DAMMIN; L DEXTER
Journal:  JAMA       Date:  1964-04-13       Impact factor: 56.272

2.  Obliterative pulmonary hypertension and thrombo-embolism.

Authors:  J F GOODWIN; C V HARRISON; D E WILCKEN
Journal:  Br Med J       Date:  1963-03-16

3.  [Primary pulmonary arterial hypertension].

Authors:  W SCHWEIZER; H HERZOG; M JENNY; D von CAPELLER
Journal:  Cardiologia       Date:  1959

4.  Idiopathic pulmonary hypertension.

Authors:  J W BROWN; D HEATH; W WHITAKER
Journal:  Br Heart J       Date:  1957-01

5.  Unrecognized emboli to the lungs with subsequent cor pulmonale.

Authors:  W R OWEN; W A THOMAS; B CASTLEMAN; E F BLAND
Journal:  N Engl J Med       Date:  1953-12-03       Impact factor: 91.245

6.  [Primary arterial pulmonary hypertension. Preliminary statistical results under the sponsorship of the Swiss Cardiological Society and with the aid the Swiss Foundation f Cardiology].

Authors:  J L Rivier
Journal:  Schweiz Med Wochenschr       Date:  1970-01-24

7.  ["Primary" pulmonary hypertension in 7 younger women. Possibility of relationship with the administration of aminorexfumarate (Menocil)].

Authors:  H Schwingshackl; H Amor; F Dienstl
Journal:  Dtsch Med Wochenschr       Date:  1969-03-28       Impact factor: 0.628

8.  [Pulmonary heart disease produced by appetite inhibitors?].

Authors:  E Lang; E J Haupt; J A Köhler; J Schmidt
Journal:  Munch Med Wochenschr       Date:  1969-02-21

9.  [Obstructive pulmonary arterial hypertension and Menocil].

Authors:  W Schweizer
Journal:  Praxis       Date:  1969-06-03

10.  Pulmonary hypertension produced in rats by ingestion of Crotalaria spectabilis seeds.

Authors:  J M Kay; P Harris; D Heath
Journal:  Thorax       Date:  1967-03       Impact factor: 9.139

View more
  11 in total

1.  Primary pulmonary hypertension.

Authors: 
Journal:  Br Med J       Date:  1976-09-25

2.  Synthesis, characterization, and monoamine transporter activity of the new psychoactive substance 3',4'-methylenedioxy-4-methylaminorex (MDMAR).

Authors:  Gavin McLaughlin; Noreen Morris; Pierce V Kavanagh; John D Power; Brendan Twamley; John O'Brien; Brian Talbot; Geraldine Dowling; Olivia Mahony; Simon D Brandt; Julian Patrick; Roland P Archer; John S Partilla; Michael H Baumann
Journal:  Drug Test Anal       Date:  2014-10-20       Impact factor: 3.345

3.  Stimulants and Pulmonary Arterial Hypertension: An Update.

Authors:  Ramon L Ramirez; Vinicio De Jesus Perez; Roham T Zamanian
Journal:  Adv Pulm Hypertens       Date:  2018

4.  Primary pulmonary hypertension.

Authors: 
Journal:  Br Med J (Clin Res Ed)       Date:  1981-01-17

Review 5.  Methamphetamine and the risk of pulmonary arterial hypertension.

Authors:  Ramon L Ramirez; Vinicio De Jesus Perez; Roham T Zamanian
Journal:  Curr Opin Pulm Med       Date:  2018-09       Impact factor: 3.155

6.  Drug-Induced Pulmonary Hypertension: The First 50 Years.

Authors:  Vinicio A de Jesus Perez
Journal:  Adv Pulm Hypertens       Date:  2017-01-01

Review 7.  Cardiac repolarisation and drug regulation: assessing cardiac safety 10 years after the CPMP guidance.

Authors:  Rashmi R Shah
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

8.  Pulmonary hypertension and fenfluramine.

Authors:  J G Douglas; J F Munro; A H Kitchin; A L Muir; A T Proudfoot
Journal:  Br Med J (Clin Res Ed)       Date:  1981-10-03

9.  Appetite suppressants and primary pulmonary hypertension in the United Kingdom.

Authors:  S H Thomas; A Y Butt; P A Corris; J J Egan; T W Higenbottam; B P Madden; P C Waller
Journal:  Br Heart J       Date:  1995-12

10.  Recent trends in pulmonary arterial hypertension.

Authors:  Rajagopalan Natarajan
Journal:  Lung India       Date:  2011-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.